- Investing Ideas
- Belgian Biotech Stocks
Belgian Biotech Stocks
Results
5
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
5 companies
UCB
Market Cap: €45.4b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€238.60
7D
-0.2%
1Y
45.8%
argenx
Market Cap: €42.9b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€690.40
7D
0.5%
1Y
32.3%
Hyloris Pharmaceuticals
Market Cap: €143.9m
Engages in the research, development, and manufacture of pharmaceutical products to address medical needs.
HYL
€5.14
7D
-3.7%
1Y
-9.5%
European Medical Solutions
Market Cap: €21.2m
Engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium and internationally.
ALEMS
€5.00
7D
2.5%
1Y
0%
Celyad Oncology
Market Cap: €13.4m
A biotechnology company, focuses on unlocking the potential of its intellectual property.
CYAD
€0.30
7D
2.7%
1Y
-36.4%